GlaxoSmithKline plc (NYSE: GSK) is extending the subsequent offering period for the cash tender offer by its wholly-owned subsidiary Pilgrim ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE